LEADERSHIP Petri Dish
USAMMDA develops a reputation for growing acquisition workforce leaders. by Mr. Jeffrey M. Soares
T
he U.S. Army Medical Materiel Development Activity (USAMMDA) at Fort Detrick, Maryland, is helping to prepare future leaders of the acquisition workforce. USAMMDA cultivates a cadre of acquisition profes-
sionals, both military and civilian, who go on to leadership roles in other areas of the Army and DOD. In fact, over the last few years, six former and current members of the USAMMDA team have been chosen from the Army Acquisition Centralized Selection List to serve as leaders in other acquisition commands throughout the country.
“Te breadth and depth of our command offer distinct exposure to a wide range of medical materiel solutions,” said Col. Ryan Bailey, USAMMDA commander. “From a military perspective, an assignment at USAMMDA offers an opportunity to be part of an organization that is focused on true acquisition medical product development, beginning at the analysis of alternatives, through the entire life cycle process.
“Understanding the acquisition component—the acquisition and sustainment strategy—while also working with stakeholders and users to understand the particular requirement provides true on-the-job, hands-on experience,” Bailey said. “It’s invaluable.”
AN ENVIRONMENT UNLIKE OTHERS As Bailey suggested, a position at USAMMDA provides a unique acquisition experience, primarily because of the organization’s role as a medical product developer. While the Army acquisition system evolved to procure items such as tanks, planes, weapons and other defense equipment, USAMMDA tailors this process to advance military medical products, devices, pharmaceuti- cals, vaccines and other medical solutions for warfighters. Te
organization is the Army’s lead resource for the advanced devel- opment, licensure and fielding of pharmaceutical products for use by the U.S. military.
Because of that focus, product and project managers at USAMMDA gain in-depth knowledge in regulatory affairs as they work with the U.S. Food and Drug Administration (FDA) to ensure the safety and efficacy of all pertinent products managed by the command, offering staff members a unique experience within Army medicine.
In this year alone, the command can claim three Army offi- cers chosen to fill leadership roles via the Centralized Selection List process: Lt. Col. Charles Ditusa, Lt. Col. Bryan Gnade and Lt. Col. Kara Schmid. Schmid currently serves USAMMDA as project manager of the Neurotrauma and Psychological Health Project Management Office. Beginning in FY 2019, she will assume the role of joint product manager for Chemical Defense Pharmaceuticals within the Medical Countermeasures Systems Joint Project Management Office at Fort Detrick.
Ditusa recently departed USAMMDA to serve as acting assis- tant product manager of the Biodefense Terapeutics Antiviral Program under the Joint Program Executive Office for Chem- ical, Biological, Radiological and Nuclear Defense. As part of his assignment, he is scheduled to assume the role of joint product manager for the Biological Defense Terapeutics office. Gnade, currently chief of the Diagnostics Systems Divi- sion of the U.S. Army Medical Research Institute of Infectious Diseases, was selected to serve as a product manager assigned to the Program Executive Office for Simulation, Training and Instrumentation.
HTTPS: / /
ASC.ARMY.MIL
123
WORKFORCE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
